Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma
Clinical trial NCT02959463 · COMPLETED
Trial details
- NCT number
- NCT02959463
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-01
- Primary completion
- 2024-11-15
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.